Arch Therapeutics, Inc. Annual Net Income (Loss) Attributable to Parent in USD from 2010 to 2023

Taxonomy & unit
us-gaap: USD
Description
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
Summary
Arch Therapeutics, Inc. quarterly/annual Net Income (Loss) Attributable to Parent history and growth rate from 2010 to 2023.
  • Arch Therapeutics, Inc. Net Income (Loss) Attributable to Parent for the quarter ending June 30, 2024 was -$5.65M, a 210% decline year-over-year.
  • Arch Therapeutics, Inc. Net Income (Loss) Attributable to Parent for the twelve months ending June 30, 2024 was -$12.3M, a 91.2% decline year-over-year.
  • Arch Therapeutics, Inc. annual Net Income (Loss) Attributable to Parent for 2023 was -$6.98M, a 32.4% decline from 2022.
  • Arch Therapeutics, Inc. annual Net Income (Loss) Attributable to Parent for 2022 was -$5.28M, a 15.5% increase from 2021.
  • Arch Therapeutics, Inc. annual Net Income (Loss) Attributable to Parent for 2021 was -$6.24M, a 33% decline from 2020.
Net Income (Loss) Attributable to Parent, Trailing 12 Months (USD)
Net Income (Loss) Attributable to Parent, Annual (USD)
Net Income (Loss) Attributable to Parent, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 -$6.98M -$1.71M -32.4% Oct 1, 2022 Sep 30, 2023 10-K 2024-02-15
2022 -$5.28M +$965K +15.5% Oct 1, 2021 Sep 30, 2022 10-K 2024-02-15
2021 -$6.24M -$1.55M -33% Oct 1, 2020 Sep 30, 2021 10-K 2022-12-28
2020 -$4.69M -$144K -3.16% Oct 1, 2019 Sep 30, 2020 10-K 2021-12-17
2019 -$4.55M +$266K +5.54% Oct 1, 2018 Sep 30, 2019 10-K 2020-12-11
2018 -$4.81M +$2.97M +38.2% Oct 1, 2017 Sep 30, 2018 10-K 2019-11-19
2017 -$7.79M -$1.8M -30% Oct 1, 2016 Sep 30, 2017 10-K 2018-12-18
2016 -$5.99M -$3.04M -103% Oct 1, 2015 Sep 30, 2016 10-K 2017-11-15
2015 -$2.95M +$5.2M +63.8% Oct 1, 2014 Sep 30, 2015 10-K 2016-12-05
2014 -$8.14M -$6.29M -339% Oct 1, 2013 Sep 30, 2014 10-K 2015-12-11
2013 -$1.85M -$1.28M -221% Oct 1, 2012 Sep 30, 2013 10-K 2014-12-12
2012 -$577K -$3.44K -0.6% Oct 1, 2011 Sep 30, 2012 10-K/A 2014-05-01
2011 -$573K -$153K -36.5% Oct 1, 2010 Sep 30, 2011 10-K/A 2014-05-01
2010 -$420K Oct 1, 2009 Sep 30, 2010 10-K/A 2014-05-01
* An asterisk sign (*) next to the value indicates that the value is likely invalid.